htert Expression correlates with myc over-expression in human prostate cancer

International Journal of Cancer

Volumn 86, Issue 3, 2000, Pages 172-176

  Latil, Alain ^a,e   Vidaud, Dominique ^b   Valéri, Antoine ^d   Fournier, Georges ^d   Vidaud, Michel ^b   Lidereau, Rosette ^a   Cussenot, Olivier ^c   Bièche, Ivan ^a,b  

^a CENTRE RENÉ HUGUENIN   (France)

^b FACULTÉ DES SCIENCES PHARMACEUTIQUES ET BIOLOGIQUES   (France)

^c SAINT LOUIS HOSPITAL   (France)

^d SERVICE DE RHUMATOLOGIE   (France)

^e Parc Scientifique de Luminy   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MYC PROTEIN; TELOMERASE; DNA; DNA BINDING PROTEIN; OLIGONUCLEOTIDE; PRIMER DNA; RNA; TELOMERASE RNA;

ARTICLE; CARCINOGENESIS; ENZYME ACTIVATION; ENZYME SUBUNIT; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; ONCOGENE MYC; PRIORITY JOURNAL; PROSTATE CANCER; TRANSACTIVATION; CELL CULTURE; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; LABORATORY DIAGNOSIS; MALE; METHODOLOGY; PROSTATE TUMOR; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

DNA PRIMERS; DNA, NEOPLASM; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MYC; HUMANS; MALE; OLIGONUCLEOTIDES; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-MYC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; SPECIMEN HANDLING; TELOMERASE; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0034688946     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0215(20000320)89:2<172::aid-ijc12>3.0.co;2-8     Document Type: Article

References (25)

1. ALTSCHUL, S.F., GISH, W., MILLER, W., MYERS, E.W. and LIPMAN, D.J., Basic local alignment search tool. J. mol. Biol., 215, 403-410 (1990).
2. BALAJI, K.C., KOUL, H., MITRA, S., MARAMAG, C., REDDY. P., MENON, N., MALHOTRA, R.K. and LAXMANAN, S., Antiproliferative effects of c-myc anti-sense oligonucleotide in prostate-cancer cells: a novel therapy in prostate cancer. Urology, 50, 1007-1015 (1997).
3. BIÈCHK, I., LAURENDEAU, I., TOZLU, S., OLIVI, M., VIDAUD, D., LIDEREAU, R. and VIDAUD, M., Quantitation of myc-gene expression in sporadic breast tumors with a real-time reverse transcription-PCR assay. Cancer Res., 59, 2759-2765 (1999).
4. BOUCHARD. C., STALLER, P. and EILERS, P., Control of cell proliferation by myc. Trends Cell Biol., 8, 202-206 (1998).
5. CHOMCZYNSKI, P. and SACCHI, N., Single-step method of RNA isolation by acid-guanidium-thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159 (1987).
6. Fox, S.B., PERSAD, A.R., ROYDS, J., KORE, R.N., SILCOCKS. P.B. and COLLINS, C.C., p53 and c-myc expression in stage-A1 prostatic adenocarcinoma: useful prognostic determinants? J. Urol., 150, 490-494 (1993).
7. GREENBERG, R.A., O'HAGAN, R.C, DENG, H., XIAO, Q., HANN, S.R., ADAMS, R.R., LICHTSTEINER, S., CHIN, L., MORIN, G.B., and DEPINHO, R.A., Telomerase reverse-transcriptase gene is a direct target of c-myc but is not functionally equivalent in cellular transformation. Oncogene, 18, 1219-1226 (1999).
8. HAHN, W.C., COUNTER, CM., LUNDBERG, A.S., BEIJERSBERGEN, R.L., BROOKS, M.W. and WEINBERG, R.A., Creation of human tumour cells with defined genetic elements. Nature Med., 400, 464-468 (1999).
9. HARLEY, C.B. and KIM, N.W., Telomerase and cancer. In: V.T. DE VITA, S. HELLMAN and S.A. ROSENBERG; (eds.). Important advances in oncology, pp. 57-67. Lippincott, Philadelphia (1996).
10. HE, T-C., SPARKS, A.B., RAGO, C., HERMEKIN, H., ZAWEL, L., DA COSTA, L.T., MORIN, P.J., VOGELSTEIN, B. and KINZLER, K.W., Identification of c-myc as a target of the APC pathway. Science. 281, 1509-1512 (1998).
11. HENRIKSSON M. and LUSCHER B., Proteins of the myc network: essential regulators of cell growth and differentiation. Advanc. Cancer Res., 68, 109-182 (1996).
12. LATIL, A. and LIDEREAU, R., Genetic aspects of prostate cancer. Virchows Arch. (B), 432, 389-406 (1998).
13. LIN, Y., UEMURA, H., FUJINAMI, K., HOSAKA, M., HARADA, M. and KUBOTA, Y., Telomerase activity in primary prostate cancer. J. Urol., 157, 1161-1165 (1997).
14. MELLINGER, G.T., GLEASON, D. and BAILAR, J.,3D., The histology and prognosis of prostatic cancer. J. Urol., 97, 331-337 (1967).
15. NAG, A. and SMITH, R.G., Amplification, rearrangement and elevated expression of c-myc in the human prostatic-carcinoma cell line LNCaP. Prostate, 15, 115-122 (1989).
16. NAKAMURA, T.M., MORIN, G.B., CHAPMAN, K.B., WEINRICH, S.L., ANDREWS, W.H., LINGNER, J., HARLEY, C.B. and CECH, T.R., Telomerase catalytic sub-unit homologs from fission yeast and human. Science, 277, 955-959 (1997).
17. PROCHOWNIK, E.V., EACLE GROVE, L., DEUBLER, D., ZHU, X.L., STEPHENSON, R.A., ROHR, L.R., YIN, X. and BROTHMAN, A.R., Commonly occurring loss and mutation of the MXII gene in prostate cancer. Genes Chromosomes Cancer, 22, 295-304 (1998).
18. SAKAMURO, D., ELLIOTT, K.J., WECHSLER-REYA, R. and PRENDERGAST, G.C., BINI is a novel myc-interacting protein with features of a tumour suppressor. Nature Genet., 14, 69-77 (1996).
19. SNIJDERS, P.J.F., VAN DUIN, M., WALBOOMERS, J.M.M., STEENBERGEN, R.D.M., RISSE, E.K.J., HELMERHORST, T.J.M., VERHEIJEN, R.H.M. and MEIJER, C.J.L.M., Telomerase activity exclusively in cervical carcinomas and a sub-set of cervical intra-epithelial neoplasia grade-III lesions: strong association with elevated messenger-RNA levels of its catalytic sub-unit and high-risk human-papillomavirus DNA. Cancer Res., 58, 3812-3818 (1998).
20. SOMMERFELD, H-J., MEEKER, A.K., PIATYSZEK, M.A., BOVA, G.S., SHAY, J.W. and COFFEY, D.S., Telomerase activity: a prevalent marker of malignant human prostate tissue. Cancer Res., 56, 218-222 (1996).
21. VISAKORPI, T., KALLIONIEMI, A.H., SYVSNEN, A-C., HYYTINEN, E.R., KARHU, R., TAMMELLA, T., ISOLA, J.J. and KALLIONIEMI, O-P., Genetic-changes in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Res., 55, 342-347 (1995).
22. VOELLER, H.J., TRUICA, C.I. and GELMANN, E.P., Beta-catenin mutations in human prostate cancer. Cancer Res., 58, 2520-2523 (1998).
23. WANG, J., XIE, L.Y., ALLAN, S., BEACH, D. and HANNON, G.J., myc activates telomerase. Gene Dev., 12, 1769-1774 (1998).
24. WANG, Q., ZHANG, H., KAJINO, K. and GREENE, M.I., BRCA1 binds c-myc and inhibits its transcriptional and transforming activity in cells. Oncogene, 17, 1939-1948 (1998).
25. Wu, K-J., GRANDORI, C., AMACKER, M., SIMON-VERMOT, N., POLACK, A., LINGNER, J. and DALLA-FAVERA, R., Direct activation of TERT transcription by c-myc. Nature Genet., 21, 220-224 (1999).